The SDHC Health & Wellbeing Podcast

 

Episode 05 - Deprescribing in Frailty: A Conversation with Kayt Blythin

Welcome to SDHC's Health and Wellbeing podcast! In this episode, Kayt shares her journey and the evolving role of pharmacists in healthcare. She highlights the collaborative efforts with the National Health Innovation Service and the proactive management of polypharmacy. Kayt and our host, Dr Nick Harvey, delve into the complexities of deprescribing, the impact of frailty on medication management, and the delicate balance between following guidelines and individual patient needs.

Discover the key considerations for deprescribing, including the role of anticholinergic medications, blood pressure management, and the importance of shared decision-making. Kayt also provides insights into the practical challenges and rewards of reducing medication burden for elderly patients, aiming to improve their quality of life.

 

Deprescribing in Frailty: A Conversation with Kayt Blythin

Topics & Discussion Points

Episode 05 - Deprescribing in Frailty: A Conversation with Kayt Blythin

  • 00:00:00 Introduction
  • 00:00:58 Kate Blythin’s Career Journey
  • 00:02:50 Diverse Opportunities in Pharmacy
  • 00:05:02 The Grey World of Guidelines
  • 00:06:14 Passion for Deprescribing in Frailty
  • 00:08:32 Balancing Medication Risks in Frailty
  • 00:10:23 Understanding Frailty Definitions
  • 00:13:04 Impact of Baseline Changes in Frailty
  • 00:15:45 Focus on Medication Benefit vs. Harm
  • 00:17:41 Identifying Anticholinergic Medications
  • 00:21:21 Seeking Guidance on Medication Reduction
  • 00:23:56 Proactive Approach to Medication Management
  • 00:27:34 Exploring Antipsychotics in Dementia
  • 00:32:31 Managing Risks of Antipsychotic Medications
  • 00:36:38 Importance of Deprescribing Alendronic Acid
  • 00:39:58 Balancing Medication Pros and Cons
  • 00:44:46 Recommendation: Dr. Lucy Pollock’s Book
  • 00:46:37 Looking Ahead to AI in Health with Keith Grimes
health-wellbeing-podcast-cover-7-1

Published: Aug 7, 2024